Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: A prospective study

Journal of Children's Orthopaedics

Volumn 2, Issue 1, 2008, Pages 29-35

  Fattal Valevski, Aviva ^a,b   Domenievitz, Dafna ^a   Giladi, Nir ^a   Wientroub, Shlomo ^a   Hayek, Shlomo ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Botulinum toxin; Cerebral palsy; Long term effect; Repeated injections

Indexed keywords

EID: 39549121467     PISSN: 18632521     EISSN: 18632548     Source Type: Journal    
DOI: 10.1007/s11832-007-0075-8     Document Type: Article

References (25)

1. Cosgrove AP, Corry IS, Graham HK (1994) Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 36:386-396
2. Calderon-Conzalez R, Calderon-Sepulveda R, Rincon-Reyes M, Garcia-Ramirez J, Mino-Arango E (1994) Botulinum toxin A in management of cerebral palsy. Pediatr Neurol 10:284-288
3. Gooch JL, Sandell TV (1996) Botulinum toxin for spasticity and athetosis in children with cerebral palsy. Arch Phys Med Rehabil 77:508-511
4. Koman LA, Mooney JF 3rd, Smith BP, Goodman A, Mulvaney T (1994) Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop 14:299-303
5. Boyd R, Graham HK (1997) Botulinum toxin A in the management of children with cerebral palsy: Indications and outcome. Eur J Neurol 4:S15-S22
6. Wong V (1998) Use of botulinum toxin injection in 17 children with spastic cerebral palsy. Pediatr Neurol 18:124-131
7. Corry IS, Cosgrove AP, Duffy CM, Taylor TC, Graham HK (1999) Botulinum toxin A in hamstring spasticity. Gait Posture 10:206-210
8. Ade-Hall RA, Moore AP (2004) Botulinum toxin type A in the treatment of lower limb spasticity in CP (Cochrane review) In: The Cochrane library, issue 1. Wiley, Chichester
9. Koman LA, Brashear A, Rosenfeld S, Chambers H, Russman B, Rang M, Root L, Ferrani E, Garcia de Yebens Prous J, Smith BP, Turkel K, Walcott JM, Molloy PT (2001) Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: A multicenter, open-label clinical trial. Pediatrics 108:1062-1071
10. Eames NW, Baker R, Hill N, Graham K, Taylor T, Cosgrove A (1999) The effect of botulinum toxin A on gastrocnemius length: Magnitude and duration of response. Dev Med Child Neurol 41:226-232
11. Metaxiotis D, Siebel A, Doederlein L (2002) Repeated botulinum toxin A injections in the treatment of spastic equinus foot. Clin Orthop Rel Res 394:177-185
12. Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG, Mubarak SJ (1999) Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 10:1-9
13. Gormley ME, Gaebler-Spira D, Delgado MR (2001) Use of botulinum toxin in pediatric patients with cerebral palsy: A three-center retrospective chart review. J Child Neurol 16:113-118
14. Watanabe Y, Bakheit AMO, McLellan DL (1998) A study of the effectiveness of botulinum toxin type A (Dysport) in the management of muscle spasticity. Disabil Rehabil 20:62-65
15. Wong AM, Pei YC, Lui TN, Chen CL, Wang CM, Chung CY (2005) Comparison between botulinum toxin type A injection and selective posterior rhizotomy in improving gait performance in children with cerebral palsy. J Neurosurg 102:385-389
16. Wood E, Rosenbaum P (2000) The gross motor function classification system for cerebral palsy: A study of reliability and stability over time. Dev Med Child Neurol 42:292-296
17. Russell DJ, Rosenbaum PL, Cadman DT, Gowland C, Hardy S, Jarvis S (1989) The gross motor function measure: A means to evaluate the effects of physical therapy. Dev Med Child Neurol 31:341-352
18. Russell DJ, Rosenbaum PL, Avery LM, Lane M (2002) Gross motor function measure (GMFM-66 and GMFM-88) user's manual. Mac Keith Press, Cambridge University Press, (Appendix 4) pp 204-208
19. Graham HK, Aoki KR, Autti-Ramo I, Boyd RN, Delgado MR, Gaebler-Spira DJ, Gormley ME, Guyer BM, Heinen F, Holton AF, Matthews D, Molenaers G, Motta F, Garcia Ruiz PJ, Wissel J (2000) Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 11:67-79
20. Gough M, Fairhurst C, Shortland AP (2005) Botulinum toxin and cerebral palsy: Time for reflection? Dev Med Child Neurol 47:709-712
21. Koman AL, Mooney JF 3rd, Smith BP, Walker F, Leon JM (2000) Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop 20:108-115
22. Ubhi T, Bhakta B, Ives H, Allgar V, Roussounis SH (2000) Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child 83:481-487
23. Massin M, Alllington N (1999) Role of exercise testing in the functional assessment of cerebral palsy children after botulinum A toxin injection. J Pediatr Orthop 19:362-365
24. Fattal-Valevski A, Giladi N, Domanievitz D, Zuk L, Masterman R, Harel S, Wientroub S, Hayek S (2002) Parameters for predicting favorable responses to botulinum toxin in children with cerebral palsy. J Child Neurol 17:272-277
25. Herrmann J, Geth K, Mall V, Bigalke H, Schulte Monting J, Linder M, Kirschner J, Berweck S, Korinthenberg R, Heinen F, Fietzek UM (2004) Clinical impact of antibody formation to botulinum toxin A in children. Ann Neurol 55:732-735